Cite
APA Citation
Liefferinckx, C., Verstockt, B., Gils, A., Tops, S., Van Moerkercke, W., Vermeire, S., & Franchimont, D. (2019). impact of first-line infliximab on the pharmacokinetics of second-line vedolizumab in inflammatory bowel diseases. United European Gastroenterology journal, 7(6), 750–758. http://access.bl.uk/ark:/81055/vdc_100090410969.0x00001b